-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Synthetic Routes of 1H-Purin-6-amine, phosphate (1:?) in the Chemical Industry
1H-Purin-6-amine, phosphate, commonly referred to as 1H-Purine-6-amine monophosphate, is a derivative of the naturally occurring purine base, adenine.
It is a crucial intermediate in the synthesis of several important pharmaceuticals, including antiviral drugs and anticancer agents.
As a result, the synthesis of 1H-Purin-6-amine, phosphate has been extensively studied in the chemical industry.
This article will discuss the various synthetic routes for the production of 1H-Purin-6-amine, phosphate.
One of the most common methods for the synthesis of 1H-Purin-6-amine, phosphate is through the use of the Halogenation-Hydrolysis method.
This process involves the treatment of adenine with chlorine or bromine, followed by hydrolysis to generate the 6-amino-purine derivative.
The reaction can be catalyzed by bases such as sodium hydroxide or potassium hydroxide, and the resulting product is then treated with phosphorus oxychloride to form 1H-Purin-6-amine, phosphate.
Another method for the synthesis of 1H-Purin-6-amine, phosphate is through the use of the Peterson's synthesis.
This process involves the treatment of adenine with chloroform, followed by the addition of a base such as sodium hydroxide.
The resulting product is then treated with chlorophosphorus acid to generate 1H-Purin-6-amine, phosphate.
A third synthetic route for 1H-Purin-6-amine, phosphate is through the use of the Grignard reaction.
This process involves the treatment of adenine with magnesium metal in the presence of a polar protic solvent such as ether or THF.
The resulting product is then treated with phosphorus trichloride to form 1H-Purin-6-amine, phosphate.
There are also several other synthetic routes for the production of 1H-Purin-6-amine, phosphate, including the use of reagents such as methyl iodide, dimethyl sulfate, and p-toluenesulfonic acid.
These methods can be more elaborate and require the use of specialized equipment and conditions.
Once synthesized, 1H-Purin-6-amine, phosphate can be further processed or modified to generate the desired pharmaceutical product.
For example, the compound can be treated with sodium hydroxide to generate the free base, which can then be converted to the acid sulfate or sulfate salt.
The 6-amino-purine derivative can also be treated with a variety of functional groups to generate modified compounds with specific properties or applications.
In conclusion, the synthetic routes for the production of 1H-Purin-6-amine, phosphate are many and varied, with different methods being more appropriate depending on the desired end product and production scale.
Regardless of the specific synthetic route selected, the ability to generate 1H-Purin-6-amine, phosphate is of critical importance in the pharmaceutical industry and continues to be the subject of ongoing research and development.